34 results
Page 2 of 2
PREC14A
fpckbq0fujlq4n
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
PRRN14A
f5m m8700ujl
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
PREC14A
yho6e
11 Apr 22
Preliminary proxy with contested solicitation
6:44am
10-K
fj32zt qagsuhri
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
t8b4ikj5ldrb868qpbya
23 Feb 22
Adagio Therapeutics Announces David Hering Appointed Interim Chief Executive Officer
5:07pm
8-K
EX-99.1
no5cnwhyf vvn5y
22 Feb 22
Adagio Therapeutics Announces CEO Succession Plan
7:57am
10-Q
soa24aiojuu
20 Sep 21
Quarterly report
4:17pm
424B4
sydjnhg3
6 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1/A
EX-1.1
f7stbd w46r7rb4s
2 Aug 21
IPO registration (amended)
6:20am
S-1/A
hd8mp1q1ptf7erlodab2
2 Aug 21
IPO registration (amended)
6:20am
S-1
nq9k ne19
16 Jul 21
IPO registration
4:56pm
DRS/A
zc15vx6pzwn
28 Jun 21
Draft registration statement (amended)
12:00am
DRS
3ddkz 03r3vr6
21 May 21
Draft registration statement
12:00am